Transient hypopigmentation in a black preterm newborn managed with Tegaderm®.

Authors

  • D.U. De Rose
  • G. Barone
  • C. Aurilia
  • S. Frezza
  • F. Gallini

DOI:

https://doi.org/10.26326/2281-9649.28.4.1913

Keywords:

Tegaderm®, Hypopigmentation, Preterm newborn, Dark skin, Side effects

Abstract

The transepidermal water loss is high in the newborn with a very low weight (ELBW) at birth. Recent studies show that the use of Tegaderm® in the ELBW newborn significantly reduces the problems resulting from the loss of water through the epidermis. A hypopigmentation secondary to the use of Tegaderm® was described.

Published

2018-12-13

How to Cite

De Rose, D., Barone, G., Aurilia, C., Frezza, S., & Gallini, F. (2018). Transient hypopigmentation in a black preterm newborn managed with Tegaderm®. European Journal of Pediatric Dermatology, 28(4), 208–210. https://doi.org/10.26326/2281-9649.28.4.1913

Issue

Section

Original articles